Esketamine hydrochloride - Depression
You are here : Home > Formulary Search > Esketamine hydrochloride - Depression
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Nasal spray
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Esketamine hydrochloride
Indication :
Depression
Group Name :
Keywords :
Brand Names Include :
Spravato
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Esketamine hydrochloride is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Depression.
- Amitriptyline hydrochloride
- Bupropion hydrochloride
- Citalopram
- Clomipramine hydrochloride
- Duloxetine hydrochloride
- Escitalopram
- Fluoxetine hydrochloride
- Flupentixol
- Fluvoxamine maleate
- Imipramine hydrochloride
- Isocarboxazid
- Lithium - adults
- Lofepramine hydrochloride
- Mianserin hydrochloride
- Mirtazapine
- Moclobemide
- Nortriptyline
- Paroxetine hydrochloride
- Phenelzine sulfate
- Quetiapine
- Reboxetine
- Sertraline
- Tranylcypromine sulfate
- Trimipramine maleate
- Venlafaxine
- Vortioxetine
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has confirmed a NON-FORMULARY traffic light status for esketamine for treating major depressive disorder in adults at imminent risk of suicide.
This decision is in view of the NICE terminated Technology Appraisal for esketamine for this indication